Table 3. Comparison of patients with present and absent sTLRs in all three CSF samples.
sTLR2 and 4 present in CSF | sTLR2 and 4 absent in CSF | P value | |
---|---|---|---|
Number of patients | 13 | 5 | |
Male | 9 (69%) | 4 (80%) | 1.00 |
Age (years) | 56.69 ± 19.9 | 57.00 ± 12.0 | .975 |
Aneurysm location | .467 | ||
Middle cerebral artery | 3 (23%) | 1 (20%) | |
Anterior cerebral artery | 3 (23%) | 1 (20%) | |
Anterior communicating artery | 6 (46%) | 1 (20%) | |
Basilar artery | 1 (8%) | 1 (20%) | |
Posterior cerebral artery | 0 | 1 (20%) | |
Aneurysmal size (mm) | 4.2 ± 1.3 | 5.6 ± 2.3 | .977 |
Cerebral infarction due to DCI on CT | 10 (77%) | 3 (60%) | .583 |
Intracerebral haemorrhage on CT | 11 (84%) | 2 (40%) | .099 |
Intraventricular blood on CT | 13 (100%) | 13 (100%) | 1.00 |
Modified Fisher CT score | 4 (2–4) | 4 (2–4) | .909 |
WFNS score on admission | 4 (3–5) | 4 (4–5) | .958 |
HH score on admission | 4 (4–5) | 4 (4–4) | .250 |
GCS on admission | 9 (5–12) | 9 (5–9) | 1.00 |
CRP level (mg/l) | 89.1 ± 88.2 | 97.5 ± 82.6 | .844 |
WBC count (106/mm3) | 12.3 ± 4.1 | 15.8 ± 9.5 | .280 |
Hgb level (mg/dl) | 11.4 ± 2.6 | 13.7 ± 2.6 | .106 |
Treatment outcome (GOS at 3 months) | 2 (1–5) | 3 (1–4) | .918 |
Values are presented as mean and standard deviations if normally distributed numerical data; median and interquartile range if ordinal data or non-normally distributed numerical data; counts and percentage if categorical data. Abbreviations: sTLR = soluble Toll-like receptor; DCI = delayed cerebral ischaemia; CT = computed tomography; WFNS = World Federation of Neurosurgical Societies scale; HH = Hunt and Hess scale; GCS = Glasgow Coma Scale; CRP = C-reactive protein; WBC = white blood cell; Hgb = plasma haemoglobin; GOS = Glasgow outcome scale.